RU2007144531A - Новые кристаллические формы тиотропийбромида - Google Patents

Новые кристаллические формы тиотропийбромида Download PDF

Info

Publication number
RU2007144531A
RU2007144531A RU2007144531/04A RU2007144531A RU2007144531A RU 2007144531 A RU2007144531 A RU 2007144531A RU 2007144531/04 A RU2007144531/04 A RU 2007144531/04A RU 2007144531 A RU2007144531 A RU 2007144531A RU 2007144531 A RU2007144531 A RU 2007144531A
Authority
RU
Russia
Prior art keywords
tiotropium bromide
crystalline
ray powder
diffraction pattern
powder diffraction
Prior art date
Application number
RU2007144531/04A
Other languages
English (en)
Russian (ru)
Inventor
Шерри Л. МОРИЗЕТТЕ (US)
Шерри Л. МОРИЗЕТТЕ
Марк Д. ТАУА (US)
Марк Д. ТАУА
Марк А. ОЛИВЕЙРА (US)
Марк А. ОЛИВЕЙРА
Original Assignee
БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE)
Берингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE), Берингер Ингельхайм Интернациональ Гмбх filed Critical БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE)
Publication of RU2007144531A publication Critical patent/RU2007144531A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RU2007144531/04A 2005-05-02 2006-04-21 Новые кристаллические формы тиотропийбромида RU2007144531A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67676005P 2005-05-02 2005-05-02
US60/676,760 2005-05-02

Publications (1)

Publication Number Publication Date
RU2007144531A true RU2007144531A (ru) 2009-06-10

Family

ID=36617384

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007144531/04A RU2007144531A (ru) 2005-05-02 2006-04-21 Новые кристаллические формы тиотропийбромида

Country Status (13)

Country Link
US (1) US20060246009A1 (enExample)
EP (1) EP1879888A2 (enExample)
JP (1) JP2008540367A (enExample)
KR (1) KR20080007656A (enExample)
CN (1) CN101203513A (enExample)
AU (1) AU2006243239A1 (enExample)
BR (1) BRPI0611091A2 (enExample)
CA (1) CA2606552A1 (enExample)
IL (1) IL187054A0 (enExample)
MX (1) MX2007013691A (enExample)
RU (1) RU2007144531A (enExample)
WO (1) WO2006117300A2 (enExample)
ZA (1) ZA200708175B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1966196A2 (en) * 2005-12-19 2008-09-10 Sicor, Inc. Pure and stable tiotropium bromide
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
CN102731494A (zh) 2005-12-19 2012-10-17 西科尔公司 噻托溴铵的新形式及其制备方法
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide
CN100999521B (zh) * 2006-01-13 2010-12-08 江苏正大天晴药业股份有限公司 结晶性抗胆碱药噻托溴铵
US20080051582A1 (en) 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
EP1923393A1 (en) * 2006-11-17 2008-05-21 Boehringer Ingelheim Pharma GmbH & Co. KG Crystalline form of tiotropium bromide and urea
GB0716026D0 (en) * 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
WO2010101538A2 (en) 2009-03-06 2010-09-10 Bilgic Mahmut New crystal forms
WO2011015883A1 (en) 2009-08-07 2011-02-10 Generics [Uk] Limited Dichloromethane solvate of tiotropium bromide and its use
US8697719B2 (en) * 2009-08-07 2014-04-15 Generics [Uk] Limited Anhydrate of tiotropium bromide
TR201007108A2 (tr) * 2010-08-25 2012-03-21 B�Lg�� Mahmut Yeni tiotropyum bromür kristali ve üretim yöntemi.@
TR201101897A2 (tr) * 2011-02-28 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür içeren kristal madde
CZ304368B6 (cs) 2011-11-28 2014-04-02 Zentiva, K.S. Směsný solvát tiotropium bromidu a způsob jeho přípravy
CN103130798B (zh) * 2011-11-30 2015-12-02 连云港润众制药有限公司 噻托溴铵的结晶
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
PT106142B (pt) 2012-02-10 2014-07-18 Hovione Farmaci Ncia S A Processo para a preparação de brometo de tiotrópio
EP2897955B1 (en) * 2012-09-11 2019-11-06 Bilgic, Mahmut New tiotropium bromide crystalline form
ES2620758T3 (es) * 2012-11-05 2017-06-29 Zentiva K.S. Estabilización de solvatos de tiotropio
EP2789611A1 (en) * 2013-04-08 2014-10-15 Cerbios-Pharma S.A. A crystalline form of tiotropium bromide
CN104341412A (zh) * 2013-07-29 2015-02-11 天津金耀集团有限公司 一种无水噻托溴铵结晶的制备方法
CN104341413A (zh) * 2013-07-29 2015-02-11 天津金耀集团有限公司 一种无水噻托溴铵的新晶型
EP2913332A1 (en) 2014-02-27 2015-09-02 Euticals S.P.A. Crystalline form of tiotropium bromide with lactose
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
EP3414243A1 (en) 2016-02-11 2018-12-19 Sima Patent Ve Lisanslama Hizmetleri Ltd. STI Crystalline form of tiotropium bromide anhydrate
PT115583B (pt) 2019-06-17 2022-05-02 Hovione Farm S A Processo contínuo para a preparação de medicamentos anticolinérgicos

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
ES2228965T3 (es) * 2000-10-12 2005-04-16 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG Monohidrato cristalino de bromuro de tiotropio, procedimiento para su preparacion y su uso para la produccion de un medicamento.
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
US6608055B2 (en) * 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
EP1401445B1 (de) * 2001-06-22 2006-08-23 Boehringer Ingelheim Pharma GmbH & Co.KG Kristallines anticholinergikum, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
DE10212264A1 (de) * 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
DE10214264A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen eines Anhydrats
US7244415B2 (en) * 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
EP1575588A1 (en) * 2002-12-16 2005-09-21 Boehringer Ingelheim Pharma GmbH & Co.KG Tiotropium containing hfc solution formulations
ME00349B (me) * 2003-11-03 2011-05-10 Boehringer Ingelheim Int Novi kristalni anhidrat sa antiholinergij skim dejstvom

Also Published As

Publication number Publication date
US20060246009A1 (en) 2006-11-02
KR20080007656A (ko) 2008-01-22
JP2008540367A (ja) 2008-11-20
CA2606552A1 (en) 2006-11-09
AU2006243239A1 (en) 2006-11-09
WO2006117300A2 (en) 2006-11-09
ZA200708175B (en) 2008-09-25
BRPI0611091A2 (pt) 2010-08-03
CN101203513A (zh) 2008-06-18
WO2006117300A3 (en) 2007-04-26
IL187054A0 (en) 2008-02-09
EP1879888A2 (en) 2008-01-23
MX2007013691A (es) 2008-01-21

Similar Documents

Publication Publication Date Title
RU2007144531A (ru) Новые кристаллические формы тиотропийбромида
Suarez et al. Synthesis and study of novel fulleropyrrolidines bearing biologically active 1, 4-dihydropyridines
EP3190102B1 (en) CRYSTAL OF (S)-1-(2-HYDROXYETHYL)-4-METHYL-N- [4-(METHYLSULFONYL)PHENYL]-5-[2-(TRIFLUOROMETHYL)&amp; xA;PHENYL]- 1H-PYRROLE-3-CARBOXAMIDE
RU2007144521A (ru) Новые кристаллические формы тиотропийбромида
Khan et al. Synthesis, characterization and in vitro antibacterial activity of new steroidal thiazolo quinoxalines
JP2008540367A5 (enExample)
Asano et al. Design, stereoselective synthesis, and biological evaluation of novel tri-cyclic compounds as inhibitor of apoptosis proteins (IAP) antagonists
CA2582233A1 (en) Process for preparing 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
CN107531678B (zh) Egfr抑制剂及其药学上可接受的盐和多晶型物及其应用
US9765056B2 (en) Indole and pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
ES2653522T3 (es) Un novedoso compuesto de triazolo-piridina
Artamonov et al. Synthesis of isomeric 6-trifluoromethyl-3-azabicyclo [3.1. 0] hexanes: Conformationally restricted analogues of 4-trifluoromethylpiperidine
AU2006304875A1 (en) Pyrazolo-pyrimidines as casein kinase II (CK2) modulators
ES2707726T3 (es) Amidas de benzoxazinona como moduladores del receptor de mineralocorticoides
AU2021201177B2 (en) Processes for preparing an FGFR inhibitor
Pires et al. New, highly potent and non-toxic, chromone inhibitors of the human breast cancer resistance protein ABCG2
AU2019386792A1 (en) Histone acetylase p300 inhibitor and use thereof
BR112013023480B1 (pt) Composto heterocíclico saturado contendo nitrogênio, seu uso e composição farmacêutica
ES2527032T3 (es) 5,6-dihidro-4H-pirrolo[1,2-a][1,4]-benzodiazepinas y 6H-pirrolo[1,2-a][1,4]benzodiazepinas sustituidas antifúngicas novedosas con derivados de benceno bicíclicos
Rao et al. Discovery of a potent, selective, and covalent ZAP-70 kinase inhibitor
ES2541668T3 (es) Proceso para preparación de solifenacina y/o de sus sales farmacéuticamente aceptables de alta pureza farmacéutica
ES2784826T3 (es) Forma cristalina de un compuesto de 4H-pirazol[1,5-]benzimidazol, procedimiento de preparación de la misma e intermediario de la misma
Kossakowski et al. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XVII. Derivatives of 1-ethoxybicyclo [2.2. 2]-oct-5-one-2, 3-dicarboximide
CN115698006B (zh) 作为Wee-1抑制剂的吡唑并[3，4-d]嘧啶-3-酮衍生物
Ge et al. The convenient synthesis of zinc chloride-free 3, 7-bis (dialkylamino) phenoxazinium salts

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20100901